Switch theme
Sign up to access all valuation multiples
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
2008
554
LTM Revenue $439M
LTM EBITDA $81.3M
$412M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Aspen Aerogels has a last 12-month revenue of $439M and a last 12-month EBITDA of $81.3M.
In the most recent fiscal year, Aspen Aerogels achieved revenue of $453M and an EBITDA of $49.6M.
Aspen Aerogels expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Aspen Aerogels valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $239M | $453M | XXX | XXX | XXX |
| Gross Profit | $5.0M | $56.9M | XXX | XXX | XXX |
| Gross Margin | 2% | 13% | XXX | XXX | XXX |
| EBITDA | -$25.2M | $49.6M | XXX | XXX | XXX |
| EBITDA Margin | -11% | 11% | XXX | XXX | XXX |
| Net Profit | -$82.7M | -$45.8M | XXX | XXX | XXX |
| Net Margin | -35% | -10% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Aspen Aerogels's stock price is $5.
Aspen Aerogels has current market cap of $436M, and EV of $412M.
See Aspen Aerogels trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $412M | $436M | XXX | XXX | XXX | XXX | $0.16 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Aspen Aerogels has market cap of $436M and EV of $412M.
Aspen Aerogels's trades at 0.9x LTM EV/Revenue multiple, and 5.1x LTM EBITDA.
Analysts estimate Aspen Aerogels's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Aspen Aerogels and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $412M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 8.3x | XXX | XXX | XXX |
| P/E | 32.6x | XXX | XXX | XXX |
| P/E/Growth | 0.3x | XXX | XXX | XXX |
| EV/FCF | -10.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAspen Aerogels's NTM/LTM revenue growth is 0%
Aspen Aerogels's revenue per employee for the last fiscal year averaged $0.8M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Aspen Aerogels's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Aspen Aerogels's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Aspen Aerogels and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 90% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -297% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 11% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.8M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 16% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 28% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| XXX | XXX | XXX | XXX | XXX | XXX | |
| Merck KGaA | XXX | XXX | XXX | XXX | XXX | XXX |
| Posco Future | XXX | XXX | XXX | XXX | XXX | XXX |
| Cosmo Advanced Materials | XXX | XXX | XXX | XXX | XXX | XXX |
| Daejoo Electronic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aspen Aerogels acquired XXX companies to date.
Last acquisition by Aspen Aerogels was XXXXXXXX, XXXXX XXXXX XXXXXX . Aspen Aerogels acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Aspen Aerogels founded? | Aspen Aerogels was founded in 2008. |
| Where is Aspen Aerogels headquartered? | Aspen Aerogels is headquartered in United States of America. |
| How many employees does Aspen Aerogels have? | As of today, Aspen Aerogels has 554 employees. |
| Who is the CEO of Aspen Aerogels? | Aspen Aerogels's CEO is Mr. Donald R. Young. |
| Is Aspen Aerogels publicy listed? | Yes, Aspen Aerogels is a public company listed on NYS. |
| What is the stock symbol of Aspen Aerogels? | Aspen Aerogels trades under ASPN ticker. |
| When did Aspen Aerogels go public? | Aspen Aerogels went public in 2014. |
| Who are competitors of Aspen Aerogels? | Similar companies to Aspen Aerogels include e.g. , Merck KGaA, Posco Future, Cosmo Advanced Materials. |
| What is the current market cap of Aspen Aerogels? | Aspen Aerogels's current market cap is $436M |
| What is the current revenue of Aspen Aerogels? | Aspen Aerogels's last 12-month revenue is $439M. |
| What is the current EBITDA of Aspen Aerogels? | Aspen Aerogels's last 12-month EBITDA is $81.3M. |
| What is the current EV/Revenue multiple of Aspen Aerogels? | Current revenue multiple of Aspen Aerogels is 0.9x. |
| What is the current EV/EBITDA multiple of Aspen Aerogels? | Current EBITDA multiple of Aspen Aerogels is 5.1x. |
| What is the current revenue growth of Aspen Aerogels? | Aspen Aerogels revenue growth between 2023 and 2024 was 90%. |
| Is Aspen Aerogels profitable? | Yes, Aspen Aerogels is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
